Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
King of Prussia, PA: RBQM leader, CluePoints, has today announced that Amit Patel will join as...
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Press Release
King of Prussia, PA – March 23rd, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Press Release
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face...
- Press Release
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper...
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Press Release
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has...
- Press Release
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical...
- Press Release
Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS...
- Press Release
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Press Release
Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum...
- Press Release
Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day...
- Press Release
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS,...
- Press Release
For well over a year now, the clinical research community has been hard at work to...
- Press Release
Risk-Based Monitoring (RBM) is the future of clinical trials. Yet, despite significant progress in recent years,...
- Press Release
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The...
- Press Release
If it isn’t documented, it didn’t happen. This mindset has shaped the way clinical monitoring activities,...
- Featured Article
Clinical trials are undergoing a period of change. Innovative uses of artificial intelligence (AI) are unlocking...
Source: Applied Clinical Trials
- Featured Article
Safety reporting is a critical aspect of clinical trial quality, directly impacting patient safety and regulatory...
Source: Applied Clinical Trials
- Featured Article
In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes...
Source: Clinical Research News
- Featured Article
The theme for this year’s International Women’s Day (IWD) on 8th March was ‘Give to Gain’....
Source: Pharmaphorum
- Featured Article
Quality tolerance limits (QTLs) are trial-level thresholds on critical-to-quality (CtQ) factors—key measures where sustained deviation could...
Source: Applied Clinical Trials
- Featured Article
Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional,...
Source: Discover Pharma
- Featured Article
Analysis of more than 880 clinical trials shows that while statistical data monitoring and key risk...
Source: Applied Clinical Trials
- Featured Article
As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards....
Source: PharmaVoice
- Featured Article
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News...
Source: Clinical Research News
- Featured Article
Dan Beaudry, market owner for risk-based quality management (RBQM) at CluePoints, explains how regulatory shifts and...
Source: Discover Pharma
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
